180 related articles for article (PubMed ID: 17070431)
1. Inability to upregulate cytochrome P450 4A and 2C causes salt sensitivity in young Sprague-Dawley rats.
Sankaralingam S; Desai KM; Glaeser H; Kim RB; Wilson TW
Am J Hypertens; 2006 Nov; 19(11):1174-80. PubMed ID: 17070431
[TBL] [Abstract][Full Text] [Related]
2. Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats.
Zhou Y; Huang H; Chang HH; Du J; Wu JF; Wang CY; Wang MH
J Pharmacol Exp Ther; 2006 Apr; 317(1):11-8. PubMed ID: 16339392
[TBL] [Abstract][Full Text] [Related]
3. Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet.
Zhou Y; Lin S; Chang HH; Du J; Dong Z; Dorrance AM; Brands MW; Wang MH
Am J Hypertens; 2005 Apr; 18(4 Pt 1):530-7. PubMed ID: 15831364
[TBL] [Abstract][Full Text] [Related]
4. Effect of alcohol on cytochrome p450 arachidonic acid metabolism and blood pressure in rats and its modulation by red wine polyphenolics.
Cowpland C; Su GM; Murray M; Puddey IB; Croft KD
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):183-8. PubMed ID: 16487260
[TBL] [Abstract][Full Text] [Related]
5. Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats.
Yoshioka K; Wakino S; Homma K; Kanda T; Tatematsu S; Hasegawa K; Sugano N; Ito O; Omata K; Saruta T; Hayashi K
Obesity (Silver Spring); 2008 May; 16(5):965-71. PubMed ID: 18277387
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade.
Williams JM; Zhao X; Wang MH; Imig JD; Pollock DM
Hypertension; 2005 Aug; 46(2):366-71. PubMed ID: 15967866
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
Chábová VC; Kramer HJ; Vanecková I; Vernerová Z; Eis V; Tesar V; Skaroupková P; Thumová M; Schejbalová S; Husková Z; Vanourková Z; Kolský A; Imig JD; Cervenka L
Vascul Pharmacol; 2007; 47(2-3):145-59. PubMed ID: 17604232
[TBL] [Abstract][Full Text] [Related]
8. Clofibrate acutely reverses saline-induced endothelial dysfunction: role of calcium-activated potassium channels.
Sankaralingam S; Desai KM; Wilson TW
Am J Hypertens; 2006 Nov; 19(11):1167-73. PubMed ID: 17070430
[TBL] [Abstract][Full Text] [Related]
9. Aging increases cytochrome P450 4A modulation of alpha1-adrenergic vasoconstriction in mesenteric arteries.
Berezan DJ; Dunn KM; Falck JR; Davidge ST
J Cardiovasc Pharmacol; 2008 Mar; 51(3):327-30. PubMed ID: 18356699
[TBL] [Abstract][Full Text] [Related]
10. Improved separation and immunodetection of rat cytochrome P450 4A forms in liver and kidney.
Okita JR; Johnson SB; Castle PJ; Dezellem SC; Okita RT
Drug Metab Dispos; 1997 Aug; 25(8):1008-12. PubMed ID: 9280410
[TBL] [Abstract][Full Text] [Related]
11. Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension.
Zhou Y; Luo P; Chang HH; Huang H; Yang T; Dong Z; Wang CY; Wang MH
Kidney Int; 2008 Oct; 74(8):1040-8. PubMed ID: 18596730
[TBL] [Abstract][Full Text] [Related]
12. Effect of aging on renal cytochrome P450-dependent arachidonic acid metabolism in Dahl rats.
Omata K; Tsutsumi E; Sheu HL; Utsumi Y; Abe K
J Lipid Mediat; 1993; 6(1-3):369-73. PubMed ID: 8357995
[TBL] [Abstract][Full Text] [Related]
13. The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic rats.
Certíková Chábová V; Kramer HJ; Vanecková I; Thumová M; Skaroupková P; Tesar V; Falck JR; Imig JD; Cervenka L
Kidney Blood Press Res; 2007; 30(5):335-46. PubMed ID: 17785988
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries.
Marji JS; Wang MH; Laniado-Schwartzman M
Am J Physiol Renal Physiol; 2002 Jul; 283(1):F60-7. PubMed ID: 12060587
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier.
McCarthy ET; Sharma R; Sharma M
Kidney Int; 2005 Jan; 67(1):152-6. PubMed ID: 15610238
[TBL] [Abstract][Full Text] [Related]
16. Decreased cardiovascular responses to cisterna magna NaCl injection in hypertensive rats.
Romero-Vecchione E; Vásquez JV; Dávoli MA; Quijada G; Rosa F
Acta Cient Venez; 1996; 47(1):11-6. PubMed ID: 9334446
[TBL] [Abstract][Full Text] [Related]
17. Regulation of preglomerular microvascular 20-hydroxyeicosatetraenoic acid levels by salt depletion.
Carroll MA; Kemp R; Cheng MK; McGiff JC
Med Sci Monit; 2001; 7(4):567-72. PubMed ID: 11433178
[TBL] [Abstract][Full Text] [Related]
18. High salt intake inhibits nitric oxide synthase expression and aggravates hypertension in rats with chronic renal failure.
Campese VM; Mozayeni P; Ye S; Gumbard M
J Nephrol; 2002; 15(4):407-13. PubMed ID: 12243372
[TBL] [Abstract][Full Text] [Related]
19. 20-HETE contributes to myogenic activation of skeletal muscle resistance arteries in Brown Norway and Sprague-Dawley rats.
Frisbee JC; Roman RJ; Falck JR; Krishna UM; Lombard JH
Microcirculation; 2001 Feb; 8(1):45-55. PubMed ID: 11296852
[TBL] [Abstract][Full Text] [Related]
20. Arachidonic acid metabolism in glucocorticoid-induced hypertension.
Zhang Y; Hu L; Mori TA; Barden A; Croft KD; Whitworth JA
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):557-62. PubMed ID: 18067589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
